Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system.
Sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system
- 1 online resource (iii, 130 pages) : illustrations.
- Report / 114th Congress, 2d session, Senate ; 114-429 .
- United States. Congress. Senate. Report ; 114-429. .
Paper version available for sale by the Superintendent of Documents, United States Government Publishing Office. "February 11, 2016." CRDP Program record.
Includes bibliographical references.
Prescription pricing--United States. Drugs--Prices--United States. Generic drugs--United States. Antitrust law--United States. Competition--United States. Consumer protection--United States. Pharmaceutical industry--Moral and ethical aspects--United States.